BLOG: ORCID Adoption in the Pharma Community

2019-10-24T22:04:36Z (GMT) by Matthew Buys Paul Farrow Sarah Sabir
ORCID have been collaborating with the Open Pharma team on various outreach activities over the last two years. In this post, jointly authored by our former Engagement Director, Matt Buys, and Paul Farrow, Group Communications Director and Sarah Sabir, Associate Medical Writer, both at Oxford PharmaGenesis, we look at the adoption of ORCID across various organisations in the pharmaceutical research community.